Open AccessClinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Author(s) -
Rupesh Raina,
Ahmad Houry,
Pratik Rath,
Guneive Mangat,
Davinder Pandher,
Md. Nazrul Islam,
Ala’a Grace Khattab,
Joseph K Kalout,
Sumedha Bagga
Publication year - 2022
Publication title -
drug healthcare and patient safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.53
H-Index - 24
ISSN - 1179-1365
DOI - 10.2147/dhps.s338050
Subject(s) - autosomal dominant polycystic kidney disease , tolvaptan , medicine , tolerability , urology , nocturia , renal function , kidney , polycystic kidney disease , urinary system , adverse effect , hyponatremia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom